Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Cytogen's Quadramet approved by FDA

April 1, 1997

Syrup formulation of Zofran available in the U.K.

April 1, 1997

U.K. introduction for intranasal sumatriptan

April 1, 1997

Extended treatment with Intron A for hepatitis C cleared by FDA

April 1, 1997

Subcutaneous IL-2 boosts CD4 cell counts in HIV-infected patients

March 26, 1997

Luvox cleared for OCD in children and adolescents

March 26, 1997

Antidepressant effects of NKH-477

March 26, 1997

CPMP approves lepirudin

March 24, 1997

New formulation of podofilox receives FDA approval

March 24, 1997

RPR seeks FDA approval for new indications for Lovenox

March 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...